drugset / Trial / NCT01028079

Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain

NCT01028079

Phase 3 Completed 338 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of 1000 mg Aspirin (the study medication) by comparing it to placebo (the control group without active substance) or 400 mg Ibuprofen (the control group with an active substance) in treating the symptoms of back pain. The study is designed to develop a treatment method against back pain which will have more advantages for patients than the methods that are currently available.

Timeline

Start
2005-11
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 1000 mg
Comparator Ibuprofen Small molecule 400 mg

Indications

No indication recorded.